SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DNOW, TASK, YMAB on Behalf of Shareholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 18 2025
0mins
Source: PRnewswire
Investigation by Halper Sadeh LLC: The law firm is investigating DNOW Inc., TaskUs, Inc., and Y-mAbs Therapeutics, Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders.
DNOW Inc. Merger: DNOW's merger with MRC Global Inc. will result in DNOW shareholders owning approximately 56.5% of the combined company post-transaction.
TaskUs Sale Details: TaskUs is being sold to affiliates of Blackstone and its executives for $16.50 per share, prompting an investigation into shareholder rights.
Y-mAbs Acquisition: Y-mAbs Therapeutics is set to be sold to SERB Pharmaceuticals for $8.60 per share in cash, with Halper Sadeh LLC seeking increased consideration and additional disclosures for shareholders.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
